药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Iron
Alogliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Alogliptin.
Iron
Bisegliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Bisegliptin.
Iron
AMG-222
The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with AMG-222.
Iron
NBI-6024
The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with NBI-6024.
Iron
NN344
The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with NN344.
Iron
Voglibose
The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Voglibose.
Iron
Vildagliptin
The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with Vildagliptin.
Iron
AICA ribonucleotide
The risk or severity of hyperglycemia can be increased when Hydrocortisone aceponate is combined with AICA ribonucleotide.
Iron
Segesterone acetate
The metabolism of Segesterone acetate can be increased when combined with Hydrocortisone aceponate.
Solifenacin
Penimepicycline
Zinc chloride can cause a decrease in the absorption of Penimepicycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Eravacycline
Zinc chloride can cause a decrease in the absorption of Eravacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Pipemidic acid
Zinc chloride can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Rufloxacin
Zinc chloride can cause a decrease in the absorption of Rufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Oxolinic acid
Zinc chloride can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Sitafloxacin
Zinc chloride can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Prulifloxacin
Zinc chloride can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Pazufloxacin
Zinc chloride can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Difloxacin
Zinc chloride can cause a decrease in the absorption of Difloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Sarafloxacin
Zinc chloride can cause a decrease in the absorption of Sarafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Solifenacin
Orbifloxacin
Zinc chloride can cause a decrease in the absorption of Orbifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.